Table 2.

Adjusted Odds Ratios of Medication-Assisted Treatment Initiation for Opioid Use Disorder by Patient Characteristics (n = 1638)^*

Characteristic	Odds Ratio	95% Confidence Interval	P Value
Sex
Male	Ref
Female (ref: male)	1.04	0.82, 1.30	0.7719
Age as of date of first MAT prescription			0.0030
18 to 29	Ref
30 to 49	0.77	0.58, 1.01
50+	0.54	0.38, 0.77
Race/Ethnicity			0.7528
Non-Hispanic white	Ref
Other	0.95	0.71, 1.28
Insurance coverage at majority of visits in study period			<0.0001
Commercial	Ref
Medicaid	0.38	0.26, 0.57
Medicare	0.31	0.18, 0.53
Self-pay	0.53	0.34, 0.83
Comorbidities^†
Hypertension	0.89	0.67, 1.19	0.4495
Diabetes	0.56	0.35, 0.89	0.0135
Asthma/COPD	0.70	0.53, 0.94	0.0186
Coronary artery disease	0.54	0.24, 1.26	0.1537
Lipid disorder	0.71	0.49, 1.03	0.0714
Cancer	0.68	0.43, 1.09	0.1084
Hepatitis C	0.73	0.51, 1.05	0.0934
Psychiatric disorder^‡	1.62	1.25, 2.10	0.0003
Current tobacco use at ≥1 visit	2.46	1.95, 3.12	<0.0001

COPD, chronic obstructive pulmonary disease. MAT, medication-assisted treatment.
↵* Bolded values denote statistical significance at P < .05.
↵† Reference for each comorbid condition is the absence of the condition.
↵‡ Psychiatric disorders included anxiety disorders, posttraumatic stress disorder, schizophrenia and other psychotic disorders, depressive disorders, and bipolar disorder.